ptmscan mono methyl arginine motif  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine motif
    Ptmscan Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    ptmscan mono methyl arginine motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine motif
    Ptmscan Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    ptmscan mono methyl arginine motif kit  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine motif kit
    Ptmscan Mono Methyl Arginine Motif Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif kit/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif kit - by Bioz Stars, 2023-02
    94/100 stars

    Images

    ptmscan mono methyl arginine motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine motif
    Ptmscan Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    mono methyl arginine motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc mono methyl arginine motif
    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA <t>mono-methyl-arginine,</t> sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with <t>anti-MMA</t> antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .
    Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    1) Product Images from "Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth"

    Article Title: Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth

    Journal: Nature Communications

    doi: 10.1038/s41467-021-21963-1

    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA mono-methyl-arginine, sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .
    Figure Legend Snippet: a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA mono-methyl-arginine, sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .

    Techniques Used: Transfection, Western Blot, Mutagenesis, Methylation, In Vitro, Purification, Expressing, Staining

    a The number of arginine methylation sites detected (the sum of mono- and di-methylation sites after removing duplicates) (column 2), arginine methylation sites could be quantified (column 3), arginine methylation sites with methylation signals decreased at least two-fold (column 4) or abolished (column 5) in PRMT4-, PRMT5- or PRMT7-knockdown experiments (lane 2, 3, and 4) following mass spectrometry analysis as described in Fig. . The number of proteins encompass all these methylation sites was also shown (bottom three lanes). For comparison, data shown for PRMT7 in Fig. was also included here. b , c Motif analysis was performed for PRMT4- ( b ) and PRMT5- ( c ) regulated arginine methylation sites using iceLogo . d , f Rates of somatic mutations at all arginine sites in the proteome and PRMT4- ( d ) or PRMT5- ( f ) regulated methylation sites in human cancers ( p = 6.54e−08 ( d ) and p = 0.1684 ( f ) by the Fisher’s exact test). e , g Rates of somatic mutations in the vicinity of all arginine sites in the proteome or PRMT4- ( e ) or PRMT5- ( g ) regulated methylation sites in human cancers (±5 nucleotides) ( p = 3.89e−108 ( e ) and p = 2.57e−45 ( g ) by the Fisher’s exact test). h , i KEGG pathway analysis using Metascape for PRMT4 ( h ) and PRMT5 ( i ) methylome. Representative terms from the top 20 enriched GO term clusters were shown.
    Figure Legend Snippet: a The number of arginine methylation sites detected (the sum of mono- and di-methylation sites after removing duplicates) (column 2), arginine methylation sites could be quantified (column 3), arginine methylation sites with methylation signals decreased at least two-fold (column 4) or abolished (column 5) in PRMT4-, PRMT5- or PRMT7-knockdown experiments (lane 2, 3, and 4) following mass spectrometry analysis as described in Fig. . The number of proteins encompass all these methylation sites was also shown (bottom three lanes). For comparison, data shown for PRMT7 in Fig. was also included here. b , c Motif analysis was performed for PRMT4- ( b ) and PRMT5- ( c ) regulated arginine methylation sites using iceLogo . d , f Rates of somatic mutations at all arginine sites in the proteome and PRMT4- ( d ) or PRMT5- ( f ) regulated methylation sites in human cancers ( p = 6.54e−08 ( d ) and p = 0.1684 ( f ) by the Fisher’s exact test). e , g Rates of somatic mutations in the vicinity of all arginine sites in the proteome or PRMT4- ( e ) or PRMT5- ( g ) regulated methylation sites in human cancers (±5 nucleotides) ( p = 3.89e−108 ( e ) and p = 2.57e−45 ( g ) by the Fisher’s exact test). h , i KEGG pathway analysis using Metascape for PRMT4 ( h ) and PRMT5 ( i ) methylome. Representative terms from the top 20 enriched GO term clusters were shown.

    Techniques Used: Methylation, Mass Spectrometry

    a Overlap among PRMT4, 5, and 7 methylome is shown. Splicing factors among substrates commonly regulated by PRMT4, 5, and 7 are listed. b Metascape CORUM , analysis was performed for substrates commonly regulated by PRMT4, 5, and 7. c Motif analysis was performed for cassette exons commonly regulated by PRMT4, 5, and 7 using CentriMo (v5.0.5) . d HEK293 cells transfected with siCTL or sihnRNPA1 were subjected to alternative splicing analysis as described in Fig. . e Schematic representation of the domain architecture of hnRNPA1. Arginine (R) sites methylated by PRMT4, 5, and/or 7 in the RGG domain were highlighted in red. The PRMTs that methylated each arginine and the methylation status were indicated at the bottom. (RRM: RNA recognition motif; RGG: arginine-glycine-glycine). f HEK293 cells transfected with siCTL or sihnRNPA1 in the presence or absence of wild type (WT) or methylation mutants including R/K (4), R/K (5), R/K (7), and R/K (457) were subjected to alternative splicing analysis as described in Fig. . g HEK293 cells transfected with siCTL or siPRMT4 , 5 , or 7 were subjected to RNA-IP assay using control IgG or anti-hnRNPA1 antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). h HEK293 cells transfected with empty vector (CTL) or Flag-tagged, wild-type (WT) or methylation mutants as described in ( f ) were subjected to RNA-IP assay using anti-Flag antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). Source data are provided as a .
    Figure Legend Snippet: a Overlap among PRMT4, 5, and 7 methylome is shown. Splicing factors among substrates commonly regulated by PRMT4, 5, and 7 are listed. b Metascape CORUM , analysis was performed for substrates commonly regulated by PRMT4, 5, and 7. c Motif analysis was performed for cassette exons commonly regulated by PRMT4, 5, and 7 using CentriMo (v5.0.5) . d HEK293 cells transfected with siCTL or sihnRNPA1 were subjected to alternative splicing analysis as described in Fig. . e Schematic representation of the domain architecture of hnRNPA1. Arginine (R) sites methylated by PRMT4, 5, and/or 7 in the RGG domain were highlighted in red. The PRMTs that methylated each arginine and the methylation status were indicated at the bottom. (RRM: RNA recognition motif; RGG: arginine-glycine-glycine). f HEK293 cells transfected with siCTL or sihnRNPA1 in the presence or absence of wild type (WT) or methylation mutants including R/K (4), R/K (5), R/K (7), and R/K (457) were subjected to alternative splicing analysis as described in Fig. . g HEK293 cells transfected with siCTL or siPRMT4 , 5 , or 7 were subjected to RNA-IP assay using control IgG or anti-hnRNPA1 antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). h HEK293 cells transfected with empty vector (CTL) or Flag-tagged, wild-type (WT) or methylation mutants as described in ( f ) were subjected to RNA-IP assay using anti-Flag antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). Source data are provided as a .

    Techniques Used: Transfection, Methylation, Two Tailed Test, Plasmid Preparation

    mono methyl arginine motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc mono methyl arginine motif
    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA <t>mono-methyl-arginine,</t> sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .
    Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    1) Product Images from "Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth"

    Article Title: Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth

    Journal: Nature Communications

    doi: 10.1038/s41467-021-21963-1

    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA mono-methyl-arginine, sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .
    Figure Legend Snippet: a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA mono-methyl-arginine, sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .

    Techniques Used: Transfection, Western Blot, Mutagenesis, Methylation, In Vitro, Purification, Expressing, Staining

    a The number of arginine methylation sites detected (the sum of mono- and di-methylation sites after removing duplicates) (column 2), arginine methylation sites could be quantified (column 3), arginine methylation sites with methylation signals decreased at least two-fold (column 4) or abolished (column 5) in PRMT4-, PRMT5- or PRMT7-knockdown experiments (lane 2, 3, and 4) following mass spectrometry analysis as described in Fig. . The number of proteins encompass all these methylation sites was also shown (bottom three lanes). For comparison, data shown for PRMT7 in Fig. was also included here. b , c Motif analysis was performed for PRMT4- ( b ) and PRMT5- ( c ) regulated arginine methylation sites using iceLogo . d , f Rates of somatic mutations at all arginine sites in the proteome and PRMT4- ( d ) or PRMT5- ( f ) regulated methylation sites in human cancers ( p = 6.54e−08 ( d ) and p = 0.1684 ( f ) by the Fisher’s exact test). e , g Rates of somatic mutations in the vicinity of all arginine sites in the proteome or PRMT4- ( e ) or PRMT5- ( g ) regulated methylation sites in human cancers (±5 nucleotides) ( p = 3.89e−108 ( e ) and p = 2.57e−45 ( g ) by the Fisher’s exact test). h , i KEGG pathway analysis using Metascape for PRMT4 ( h ) and PRMT5 ( i ) methylome. Representative terms from the top 20 enriched GO term clusters were shown.
    Figure Legend Snippet: a The number of arginine methylation sites detected (the sum of mono- and di-methylation sites after removing duplicates) (column 2), arginine methylation sites could be quantified (column 3), arginine methylation sites with methylation signals decreased at least two-fold (column 4) or abolished (column 5) in PRMT4-, PRMT5- or PRMT7-knockdown experiments (lane 2, 3, and 4) following mass spectrometry analysis as described in Fig. . The number of proteins encompass all these methylation sites was also shown (bottom three lanes). For comparison, data shown for PRMT7 in Fig. was also included here. b , c Motif analysis was performed for PRMT4- ( b ) and PRMT5- ( c ) regulated arginine methylation sites using iceLogo . d , f Rates of somatic mutations at all arginine sites in the proteome and PRMT4- ( d ) or PRMT5- ( f ) regulated methylation sites in human cancers ( p = 6.54e−08 ( d ) and p = 0.1684 ( f ) by the Fisher’s exact test). e , g Rates of somatic mutations in the vicinity of all arginine sites in the proteome or PRMT4- ( e ) or PRMT5- ( g ) regulated methylation sites in human cancers (±5 nucleotides) ( p = 3.89e−108 ( e ) and p = 2.57e−45 ( g ) by the Fisher’s exact test). h , i KEGG pathway analysis using Metascape for PRMT4 ( h ) and PRMT5 ( i ) methylome. Representative terms from the top 20 enriched GO term clusters were shown.

    Techniques Used: Methylation, Mass Spectrometry

    ptmscan mono methyl arginine motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine motif
    Ptmscan Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    mma motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc mma motif
    Mma Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mma motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mma motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    ptmscan mono methyl arginine 13 motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine 13 motif
    KEY RESOURCES TABLE
    Ptmscan Mono Methyl Arginine 13 Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine 13 motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine 13 motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    1) Product Images from "Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation"

    Article Title: Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    Journal: Cancer cell

    doi: 10.1016/j.ccell.2019.07.003

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Recombinant, Luminescence Assay, MTS Assay, Knock-In, Transgenic Assay, Sequencing, Software

    ptmscan mono methyl arginine 13 motif  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc ptmscan mono methyl arginine 13 motif
    KEY RESOURCES TABLE
    Ptmscan Mono Methyl Arginine 13 Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine 13 motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine 13 motif - by Bioz Stars, 2023-02
    94/100 stars

    Images

    1) Product Images from "Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation"

    Article Title: Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    Journal: Cancer cell

    doi: 10.1016/j.ccell.2019.07.003

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Recombinant, Luminescence Assay, MTS Assay, Knock-In, Transgenic Assay, Sequencing, Software

    mma antibody conjugated beads  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc mma antibody conjugated beads
    KEY RESOURCES TABLE
    Mma Antibody Conjugated Beads, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mma antibody conjugated beads/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mma antibody conjugated beads - by Bioz Stars, 2023-02
    94/100 stars

    Images

    1) Product Images from "Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation"

    Article Title: Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    Journal: Cancer cell

    doi: 10.1016/j.ccell.2019.07.003

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Recombinant, Luminescence Assay, MTS Assay, Knock-In, Transgenic Assay, Sequencing, Software

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Cell Signaling Technology Inc ptmscan mono methyl arginine motif
    Ptmscan Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ptmscan mono methyl arginine motif kit
    Ptmscan Mono Methyl Arginine Motif Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine motif kit/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine motif kit - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc mono methyl arginine motif
    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA <t>mono-methyl-arginine,</t> sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with <t>anti-MMA</t> antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .
    Mono Methyl Arginine Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mono methyl arginine motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mono methyl arginine motif - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc mma motif
    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA <t>mono-methyl-arginine,</t> sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with <t>anti-MMA</t> antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .
    Mma Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mma motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mma motif - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ptmscan mono methyl arginine 13 motif
    KEY RESOURCES TABLE
    Ptmscan Mono Methyl Arginine 13 Motif, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptmscan mono methyl arginine 13 motif/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ptmscan mono methyl arginine 13 motif - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc mma antibody conjugated beads
    KEY RESOURCES TABLE
    Mma Antibody Conjugated Beads, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mma antibody conjugated beads/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mma antibody conjugated beads - by Bioz Stars, 2023-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA mono-methyl-arginine, sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .

    Journal: Nature Communications

    Article Title: Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth

    doi: 10.1038/s41467-021-21963-1

    Figure Lengend Snippet: a , b HEK293 cells transfected with control siRNA ( siCTL ) or siRNA against PRMT7 ( siPRMT7 ) were analyzed by immunoblotting. MMA mono-methyl-arginine, sDMA symmetric di-methyl-arginine, aDMA asymmetric di-methyl-arginine. ACTIN was served as a loading control. c HEK293 cells transfected with siCTL or siPRMT7 together with or without Flag-tagged, wild-type (WT) or enzymatic dead mutant (MT) PRMT7 were analyzed by immunoblotting. d Experimental flowchart for identification of arginine methylation sites regulated by PRMT7 or responsive to PRMT7 inhibitor SGC3027 in HEK293 cells (see detail in “Methods”). e The number of mono-methyl arginine (Rme1) sites detected (column 1), Rme1 sites could be quantified (column 2), Rme1 sites with methylation signals decreased at least two-fold (column 3) or abolished (column 4) when knocking down of PRMT7 was shown. The number of proteins encompass all these methylation sites was also shown (bottom lane). f The overlap between PRMT7 methylome and proteins of which abundance was decreased at least two-fold when PRMT7 was knocked down is shown. g In vitro methylation assay was performed by mixing purified PRMT7 with CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1 or △Np63α, followed by immunoblotting with anti-MMA antibody (top panel). Methylation was indicated by white asterisk. The expression of proteins was examined by coomassie blue staining (C.B.S) and indicated by black asterisk (bottom panel). h The expression of purified PRMT7 was examined by C.B.S and indicated by black asterisk. i In vitro methylation assay was performed by mixing purified PRMT7 with synthetic short peptides from CCT7, TFG, YBX1, CKMT1B, hnRNPK, hnRNPA2B1, and hnRNPA1 proteins. Amino (N)-terminal of histone H3 and H4 were also included. The reactions were subjected to dot blotting. aa, amino acid. j The expression of purified PRMT7 was examined by immunoblotting. k In vitro methylation assay was performed by mixing purified PRMT7 with hnRNPA1 wild-type (WT) or mutants including R/K (7) (all five arginine (R) residues methylated by PRMT7 were replaced by lysine (K)), R194K, R206K, R218K, R225K, and R232K. The reactions were subjected to immunoblotting. Source data are provided as a .

    Article Snippet: Antibodies used in this study are listed as following: Rabbit monoclonal anti-mono-methyl arginine [mme-R] (Cell Signaling Technology, 8015S, 1:2000); PTMScan® mono-methyl arginine Motif [mme-RG] Kit (Cell Signaling Technology, 12235, for immunoenrichment); Rabbit monoclonal anti-symmetric di-methyl arginine motif [sdme-R] (Cell Signaling Technology, 13222S, 1:2000); PTMScan symmetric di-methyl arginine motif [sdme-RG] (Cell Signaling Technology, 13563, for immunoenrichment); Rabbit monoclonal anti-asymmetric di-methyl arginine motif [adme-RG] (Cell Signaling Technology, 13522S, 1:2000); PTMScan asymmetric di-methyl arginine motif [adme-RG] (Cell Signaling Technology, 13474, for immunoenrichment); mouse monoclonal anti-actin (Proteintech, 66009-1-Ig, 1:2000); Mouse monoclonal anti-CARM1(3H2) (Cell Signaling Technology, 12495S, 1:2000); Rabbit monoclonal anti-PRMT5 (EPR5772) (Abcam, ab109451, 1:2000); Rabbit monoclonal anti-PRMT7 (D1K6R) (Cell Signaling Technology, 14762S, 1:2000); Rabbit monoclonal anti-hnRNPA1 (Proteintech, 11176-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPM (Proteintech, 26897-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPA2B1 (Proteintech, 14813-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPK (Proteintech, 11426-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPU (Proteintech, 14599-1-AP, 1:2000); Mouse monoclonal anti-FLAG M2 (Sigma, F1804, 1:5000); Anti-FLAG M2 Affinity Gel (Sigma, A2220, for immunoenrichment); Monoclonal Anti-HA-Agarose, clone HA-7 (Sigma, A2095, for immunoenrichment).

    Techniques: Transfection, Western Blot, Mutagenesis, Methylation, In Vitro, Purification, Expressing, Staining

    a The number of arginine methylation sites detected (the sum of mono- and di-methylation sites after removing duplicates) (column 2), arginine methylation sites could be quantified (column 3), arginine methylation sites with methylation signals decreased at least two-fold (column 4) or abolished (column 5) in PRMT4-, PRMT5- or PRMT7-knockdown experiments (lane 2, 3, and 4) following mass spectrometry analysis as described in Fig. . The number of proteins encompass all these methylation sites was also shown (bottom three lanes). For comparison, data shown for PRMT7 in Fig. was also included here. b , c Motif analysis was performed for PRMT4- ( b ) and PRMT5- ( c ) regulated arginine methylation sites using iceLogo . d , f Rates of somatic mutations at all arginine sites in the proteome and PRMT4- ( d ) or PRMT5- ( f ) regulated methylation sites in human cancers ( p = 6.54e−08 ( d ) and p = 0.1684 ( f ) by the Fisher’s exact test). e , g Rates of somatic mutations in the vicinity of all arginine sites in the proteome or PRMT4- ( e ) or PRMT5- ( g ) regulated methylation sites in human cancers (±5 nucleotides) ( p = 3.89e−108 ( e ) and p = 2.57e−45 ( g ) by the Fisher’s exact test). h , i KEGG pathway analysis using Metascape for PRMT4 ( h ) and PRMT5 ( i ) methylome. Representative terms from the top 20 enriched GO term clusters were shown.

    Journal: Nature Communications

    Article Title: Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth

    doi: 10.1038/s41467-021-21963-1

    Figure Lengend Snippet: a The number of arginine methylation sites detected (the sum of mono- and di-methylation sites after removing duplicates) (column 2), arginine methylation sites could be quantified (column 3), arginine methylation sites with methylation signals decreased at least two-fold (column 4) or abolished (column 5) in PRMT4-, PRMT5- or PRMT7-knockdown experiments (lane 2, 3, and 4) following mass spectrometry analysis as described in Fig. . The number of proteins encompass all these methylation sites was also shown (bottom three lanes). For comparison, data shown for PRMT7 in Fig. was also included here. b , c Motif analysis was performed for PRMT4- ( b ) and PRMT5- ( c ) regulated arginine methylation sites using iceLogo . d , f Rates of somatic mutations at all arginine sites in the proteome and PRMT4- ( d ) or PRMT5- ( f ) regulated methylation sites in human cancers ( p = 6.54e−08 ( d ) and p = 0.1684 ( f ) by the Fisher’s exact test). e , g Rates of somatic mutations in the vicinity of all arginine sites in the proteome or PRMT4- ( e ) or PRMT5- ( g ) regulated methylation sites in human cancers (±5 nucleotides) ( p = 3.89e−108 ( e ) and p = 2.57e−45 ( g ) by the Fisher’s exact test). h , i KEGG pathway analysis using Metascape for PRMT4 ( h ) and PRMT5 ( i ) methylome. Representative terms from the top 20 enriched GO term clusters were shown.

    Article Snippet: Antibodies used in this study are listed as following: Rabbit monoclonal anti-mono-methyl arginine [mme-R] (Cell Signaling Technology, 8015S, 1:2000); PTMScan® mono-methyl arginine Motif [mme-RG] Kit (Cell Signaling Technology, 12235, for immunoenrichment); Rabbit monoclonal anti-symmetric di-methyl arginine motif [sdme-R] (Cell Signaling Technology, 13222S, 1:2000); PTMScan symmetric di-methyl arginine motif [sdme-RG] (Cell Signaling Technology, 13563, for immunoenrichment); Rabbit monoclonal anti-asymmetric di-methyl arginine motif [adme-RG] (Cell Signaling Technology, 13522S, 1:2000); PTMScan asymmetric di-methyl arginine motif [adme-RG] (Cell Signaling Technology, 13474, for immunoenrichment); mouse monoclonal anti-actin (Proteintech, 66009-1-Ig, 1:2000); Mouse monoclonal anti-CARM1(3H2) (Cell Signaling Technology, 12495S, 1:2000); Rabbit monoclonal anti-PRMT5 (EPR5772) (Abcam, ab109451, 1:2000); Rabbit monoclonal anti-PRMT7 (D1K6R) (Cell Signaling Technology, 14762S, 1:2000); Rabbit monoclonal anti-hnRNPA1 (Proteintech, 11176-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPM (Proteintech, 26897-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPA2B1 (Proteintech, 14813-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPK (Proteintech, 11426-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPU (Proteintech, 14599-1-AP, 1:2000); Mouse monoclonal anti-FLAG M2 (Sigma, F1804, 1:5000); Anti-FLAG M2 Affinity Gel (Sigma, A2220, for immunoenrichment); Monoclonal Anti-HA-Agarose, clone HA-7 (Sigma, A2095, for immunoenrichment).

    Techniques: Methylation, Mass Spectrometry

    a Overlap among PRMT4, 5, and 7 methylome is shown. Splicing factors among substrates commonly regulated by PRMT4, 5, and 7 are listed. b Metascape CORUM , analysis was performed for substrates commonly regulated by PRMT4, 5, and 7. c Motif analysis was performed for cassette exons commonly regulated by PRMT4, 5, and 7 using CentriMo (v5.0.5) . d HEK293 cells transfected with siCTL or sihnRNPA1 were subjected to alternative splicing analysis as described in Fig. . e Schematic representation of the domain architecture of hnRNPA1. Arginine (R) sites methylated by PRMT4, 5, and/or 7 in the RGG domain were highlighted in red. The PRMTs that methylated each arginine and the methylation status were indicated at the bottom. (RRM: RNA recognition motif; RGG: arginine-glycine-glycine). f HEK293 cells transfected with siCTL or sihnRNPA1 in the presence or absence of wild type (WT) or methylation mutants including R/K (4), R/K (5), R/K (7), and R/K (457) were subjected to alternative splicing analysis as described in Fig. . g HEK293 cells transfected with siCTL or siPRMT4 , 5 , or 7 were subjected to RNA-IP assay using control IgG or anti-hnRNPA1 antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). h HEK293 cells transfected with empty vector (CTL) or Flag-tagged, wild-type (WT) or methylation mutants as described in ( f ) were subjected to RNA-IP assay using anti-Flag antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). Source data are provided as a .

    Journal: Nature Communications

    Article Title: Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth

    doi: 10.1038/s41467-021-21963-1

    Figure Lengend Snippet: a Overlap among PRMT4, 5, and 7 methylome is shown. Splicing factors among substrates commonly regulated by PRMT4, 5, and 7 are listed. b Metascape CORUM , analysis was performed for substrates commonly regulated by PRMT4, 5, and 7. c Motif analysis was performed for cassette exons commonly regulated by PRMT4, 5, and 7 using CentriMo (v5.0.5) . d HEK293 cells transfected with siCTL or sihnRNPA1 were subjected to alternative splicing analysis as described in Fig. . e Schematic representation of the domain architecture of hnRNPA1. Arginine (R) sites methylated by PRMT4, 5, and/or 7 in the RGG domain were highlighted in red. The PRMTs that methylated each arginine and the methylation status were indicated at the bottom. (RRM: RNA recognition motif; RGG: arginine-glycine-glycine). f HEK293 cells transfected with siCTL or sihnRNPA1 in the presence or absence of wild type (WT) or methylation mutants including R/K (4), R/K (5), R/K (7), and R/K (457) were subjected to alternative splicing analysis as described in Fig. . g HEK293 cells transfected with siCTL or siPRMT4 , 5 , or 7 were subjected to RNA-IP assay using control IgG or anti-hnRNPA1 antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). h HEK293 cells transfected with empty vector (CTL) or Flag-tagged, wild-type (WT) or methylation mutants as described in ( f ) were subjected to RNA-IP assay using anti-Flag antibody. n = 3 biological replicates (mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001 by unpaired Student t -test, two-tailed). Source data are provided as a .

    Article Snippet: Antibodies used in this study are listed as following: Rabbit monoclonal anti-mono-methyl arginine [mme-R] (Cell Signaling Technology, 8015S, 1:2000); PTMScan® mono-methyl arginine Motif [mme-RG] Kit (Cell Signaling Technology, 12235, for immunoenrichment); Rabbit monoclonal anti-symmetric di-methyl arginine motif [sdme-R] (Cell Signaling Technology, 13222S, 1:2000); PTMScan symmetric di-methyl arginine motif [sdme-RG] (Cell Signaling Technology, 13563, for immunoenrichment); Rabbit monoclonal anti-asymmetric di-methyl arginine motif [adme-RG] (Cell Signaling Technology, 13522S, 1:2000); PTMScan asymmetric di-methyl arginine motif [adme-RG] (Cell Signaling Technology, 13474, for immunoenrichment); mouse monoclonal anti-actin (Proteintech, 66009-1-Ig, 1:2000); Mouse monoclonal anti-CARM1(3H2) (Cell Signaling Technology, 12495S, 1:2000); Rabbit monoclonal anti-PRMT5 (EPR5772) (Abcam, ab109451, 1:2000); Rabbit monoclonal anti-PRMT7 (D1K6R) (Cell Signaling Technology, 14762S, 1:2000); Rabbit monoclonal anti-hnRNPA1 (Proteintech, 11176-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPM (Proteintech, 26897-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPA2B1 (Proteintech, 14813-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPK (Proteintech, 11426-1-AP, 1:2000); Rabbit monoclonal anti-hnRNPU (Proteintech, 14599-1-AP, 1:2000); Mouse monoclonal anti-FLAG M2 (Sigma, F1804, 1:5000); Anti-FLAG M2 Affinity Gel (Sigma, A2220, for immunoenrichment); Monoclonal Anti-HA-Agarose, clone HA-7 (Sigma, A2095, for immunoenrichment).

    Techniques: Transfection, Methylation, Two Tailed Test, Plasmid Preparation

    KEY RESOURCES TABLE

    Journal: Cancer cell

    Article Title: Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    doi: 10.1016/j.ccell.2019.07.003

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: PTMScan Mono-Methyl Arginine 13 Motif [mme-RG] Kit , Cell Signaling Technologies , Kit #12235.

    Techniques: Recombinant, Luminescence Assay, MTS Assay, Knock-In, Transgenic Assay, Sequencing, Software

    KEY RESOURCES TABLE

    Journal: Cancer cell

    Article Title: Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    doi: 10.1016/j.ccell.2019.07.003

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: After lyophilisation, each concatenated fraction was dissolved in 250 μl of 1x immuno-Affinity Purification Buffer (IAP buffer, #9993, Cell Signaling Technologies, CST) and subjected to two consecutive steps of methyl-R-peptides enrichment using the SDMA antibody-conjugated beads (PTMScan [sdme-R] Kit #13563, Cell Signaling Technologies) and the MMA antibody-conjugated beads (PTMScan Mono-Methyl Arginine Motif [mme-RG] Kit #12235, Cell Signaling Technologies), following the manufacturer’s instructions.

    Techniques: Recombinant, Luminescence Assay, MTS Assay, Knock-In, Transgenic Assay, Sequencing, Software